2022
DOI: 10.1111/jcmm.17280
|View full text |Cite
|
Sign up to set email alerts
|

LRG‐1 promotes fat graft survival through the RAB31‐mediated inhibition of hypoxia‐induced apoptosis

Abstract: Autologous adipose tissue is an ideal soft tissue filling material, and its biocompatibility is better than that of artificial tissue substitutes, foreign bodies and heterogeneous materials. Although autologous fat transplantation has many advantages, the low retention rate of adipose tissue limits its clinical application. Here, we identified a secretory glycoprotein, leucine‐rich‐alpha‐2‐glycoprotein 1 (LRG‐1), that could promote fat graft survival through RAB31‐mediated inhibition of hypoxia‐induced apoptos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 73 publications
0
2
0
Order By: Relevance
“…During the process, ADSCs can stimulate angiogenesis through differentiation into epithelial cells and release angiogenic factors by paracrine activity. Finally, dedifferentiation, which a mature adipocyte is reverted to an undifferentiated progenitor-like status under both physiological and pathological conditions, also has been reported as a mechanism explaining adipocyte plasticity ( 45 - 48 ). Therefore, the molecular mechanisms underlying the adipogenic differentiation of ADSCs still should be explored to facilitate the success of ADSCs-based therapies after breast cancer surgery.…”
Section: Discussionmentioning
confidence: 99%
“…During the process, ADSCs can stimulate angiogenesis through differentiation into epithelial cells and release angiogenic factors by paracrine activity. Finally, dedifferentiation, which a mature adipocyte is reverted to an undifferentiated progenitor-like status under both physiological and pathological conditions, also has been reported as a mechanism explaining adipocyte plasticity ( 45 - 48 ). Therefore, the molecular mechanisms underlying the adipogenic differentiation of ADSCs still should be explored to facilitate the success of ADSCs-based therapies after breast cancer surgery.…”
Section: Discussionmentioning
confidence: 99%
“…LRG1 has been shown to exert a benefcial impact on the survival and function of adipocytes. Tis can be attributed to its ability to inhibit adipocyte apoptosis through the RAS oncogene family member (RAB31) protein [23]. Currently, limited research is available on the connection between LRG1 and other adipokines.…”
Section: Discussionmentioning
confidence: 99%